N/A
N=53
Attention, Teleconferencing and Social Anxiety
Social Anxiety Disorder
Bottom Line
View on ClinicalTrials.gov: NCT04729803 ↗Enrolled (actual)
53
Serious AEs
0.0%
Results posted
Jan 2024
Primary outcome: Primary: Personal Report of Communication Apprehension Questionnaire — 88.06; 87.64; 95.69 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Experimental: Attention Guidance + Exposure (Behavioral); Active Comparator: Exposure Alone (Behavioral); Experimental: Attention Control + Exposure (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Texas at Austin
- Primary completion
- Jun 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Personal Report of Communication Apprehension Questionnaire |
70.25; 67.13; 71.00 | — |
| PRIMARY Personal Report of Communication Apprehension Questionnaire |
70.25; 67.13; 71.00 | — |
| PRIMARY Personal Report of Communication Apprehension Questionnaire |
70.25; 67.13; 71.00 | — |
| PRIMARY Leibowitz Social Anxiety Scale Questionnaire |
81.67; 50.13; 71.00 | — |
| PRIMARY Leibowitz Social Anxiety Scale Questionnaire |
81.67; 50.13; 71.00 | — |
| PRIMARY Leibowitz Social Anxiety Scale Questionnaire |
81.67; 50.13; 71.00 | — |
Summary
This study involves completing some online assessments and an intervention for social anxiety that all involve interactions with other people on a teleconferencing call.
Eligibility Criteria
Inclusion Criteria
- Age 18-75
- Fluent in English because the data collection materials have not yet been standardized in other languages
- Having access to a computer with a webcam and ability to record audio
- Personal Report of Communication Apprehension > 80
- Leibowitz Social Anxiety Scale > 30
- Meets DSM-5 Criteria for Social Anxiety Disorder
Exclusion Criteria
- Significant visual impairment precluding the use of the eye tracking equipment
- Current, or history of bipolar disorder; current, or history of psychosis
Data sourced from ClinicalTrials.gov (NCT04729803). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.